HCV-related proteins activate Kupffer cells isolated from human liver tissues

Digestive Diseases and Sciences

Volumn 56, Issue 4, 2011, Pages 1057-1064

  Hosomura, Naohiro ^a   Kono, Hiroshi ^a   Tsuchiya, Masato ^a   Ishii, Kenichi ^a   Ogiku, Masahito ^a   Matsuda, Masanori ^a   Fujii, Hideki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Hydrogen peroxide; Inflammatory cytokine; TNF ; Toll like receptor

Indexed keywords

CORE PROTEIN; CYTOCHALASIN B; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KUPFFER CELL; LIVER; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGED; ANTIBODIES, NEUTRALIZING; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHALASIN B; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-10; INTERLEUKIN-1BETA; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; MALE; MIDDLE AGED; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 79955579228     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1395-y     Document Type: Article

References (31)

1. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology. 2002;62(1):5-7. (Pubitemid 34702013)
2. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C Virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002;62(Suppl 1):8-17. (Pubitemid 34702014)
3. Tanaka Y, Hanada K, Mizokami M, et al. Inaugural article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584-15589. (Pubitemid 35403976)
4. McGuinness PH, Painter D, Davies S, McCaughan GW. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut. 2000;46:260-269.
5. Maki A, Kono H, Gupta M, et al. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol. 2007;14:1182-1190.
6. Matsumoto K, Satoh Y, Sugo H, et al. Immunohistochemical study of the relationship between 8-hydroxy-2′-deoxyguanosine levels in noncancerous region and postoperative recurrence of hepatocellular carcinoma in remnant liver. Hepatol Res. 2003;25:435-441. (Pubitemid 36519290)
7. Burgio VL, Ballardini G, Artini M, Caratozzolo M, Bianchi FB, Levrero M. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus stiology. Hepatology. 1998;27:1600-1606. (Pubitemid 28264685)
8. Wheeler MD, Kono H, Yin M, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med. 2001;31:1544-1549. (Pubitemid 34026339)
9. Rusyn I, Kadiiska MB, Dikalova A, et al. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol Pharmacol. 2001;59:744-750. (Pubitemid 32274002)
10. Dolganiuc A, Oak S, Kodys K, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004;127:1513-1524. (Pubitemid 39457776)
11. Dolganiuc A, Kodys K, Kopasz A, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and antiinflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170:5615-5624. (Pubitemid 36617852)
12. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol. 2007;82:479-487. (Pubitemid 47367138)
13. Heuff G, Meyer S, Beelen RHJ. Isolation of rat and human Kupffer cells by a modified enzymatic assay. J Immunol Meth. 1994;174:61-65. (Pubitemid 24297137)
14. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990;192:245-261. Review.
15. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938-941. (Pubitemid 28507525)
16. Zeisel MB, Koutsoudakis G, Schnober EK, et al. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology. 2007;46:1722-1731.
17. Muriel P, Alba N, Perez-Alvarez VM, Shibayama M, Tsutsumi VK. Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride. Comp Biochem Physiol C Toxicol Pharmacol. 2001;130:219-226. (Pubitemid 32905300)
18. Niemela O, Parkkila S, Bradford B, Iimuro Y, Pasanen M, Thurman RG. Effect of Kupffer cell inactivation on ethanol-induced protein adducts in the liver. Free Radic Biol Med. 2002;33:350-355. (Pubitemid 34786273)
19. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. 1999;30:186-195. (Pubitemid 29300585)
20. Ju C, Reilly TP, Bourdi M, et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol. 2002;15:1504-1513. (Pubitemid 36008198)
21. Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290:583-589.
22. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 2005;120:649-661. (Pubitemid 40343077)
23. Pham CG, Bubici C, Zazzeroni F, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529.
24. Asakawa M, Kono H, Amemiya H, et al. Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection. Int J Cancer. 2006;118:564-570. (Pubitemid 43076003)
25. Zhang H-Y, Nanji AA, Luk JM, et al. Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection. Liver Int. 2005;25:571-579. (Pubitemid 40861907)
26. Kallinowski B, Haseroth K, Marinos G, et al. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;111:269-277. (Pubitemid 28088306)
27. Farinati F, Cardin R, Bortolami M, Guido M, Rugge M. Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol. 2006;12:2065-2069.
28. Tomita M, Yamamoto K, Kobashi H, Ohmoto M, Tsuji T. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology. 1994;20:317-325. (Pubitemid 24233355)
29. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct Toll-like receptor expression in monocytes and T-cells in chronic HCV infection. World J Gastroenterol. 2006;12:1198-1204.
30. Lin RS, Lee FY, Lee SD, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol. 1995;22:165-172.
31. Plachouras D, Stamatakos M, Baziaka F, et al. Portal and systemic endotoxemia in abdominal operations: the significance of acute abdomen. J Surg Res. 2006;134:133-137. (Pubitemid 43866818)